Hybrid Conferencee

International Conference on Oncology and Cancer Treatment Innovations (ICOCTI - 26)

24th - 25th October 2026 | Dubai, UAE
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Programme

Tentative Conference Agenda

Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.

Conference Format Hybrid Conference In-person and virtual participation
Programme 2 Days 24–25 October 2026
Academic Scope 11 Tracks Conference Session Tracks
Research Scope 20 Areas Call for Papers themes
SDG Alignment 4 SDGs SDGs 3, 4, 9 and 10
Tentative Agenda & Timings

Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.

Day 01

Opening, Keynote & Technical Sessions

24 OCT 2026 HYBRID
  1. 09:00 AM 09:30 AM

    Registration, Welcome Kit Collection & Virtual Check-in

    Participant arrival, credential verification and virtual lobby access.

    HYBRID
  2. 09:30 AM 09:45 AM

    Networking Tea & Digital Welcome

    Informal networking for on-site and virtual participants.

    HYBRID
  3. 09:45 AM 10:30 AM

    Welcome Address, Opening Plenary & Keynote Presentation I

    Opening of the conference and introduction to its research focus.

    PLENARY
  4. 10:30 AM 12:30 PM

    Concurrent Technical Session I

    3 TRACKS
    Track 01
    Innovations in Immunotherapy
    34
    Track Overview

    This track will explore the latest advancements in immunotherapy for cancer treatment, focusing on novel approaches and therapies. Discussions will include the mechanisms of action, clinical outcomes, and future directions in immunotherapeutic strategies.

    Track 02
    Precision Medicine in Oncology
    39
    Track Overview

    This session will delve into the role of precision medicine in oncology, emphasizing personalized treatment plans based on genetic and molecular profiling. Participants will examine case studies and emerging technologies that enhance targeted therapies.

    Track 03
    Translational Oncology: Bridging Research and Practice
    39
    Track Overview

    This track will highlight the importance of translational research in oncology, focusing on how laboratory discoveries can be effectively translated into clinical applications. Experts will discuss successful case studies and the challenges faced in this critical process.

  5. 12:30 PM 01:30 PM

    Lunch & Networking Break

    Refreshment interval and networking opportunity.

    BREAK
  6. 01:30 PM 03:30 PM

    Concurrent Technical Session II

    3 TRACKS
    Track 04
    Tumor Biology and Microenvironment
    39
    Track Overview

    This session will investigate the complexities of tumor biology and the tumor microenvironment, including cellular interactions and signaling pathways. Researchers will present findings on how these factors influence cancer progression and treatment responses.

    Track 05
    Advancements in Clinical Trials
    39
    Track Overview

    This track will focus on innovative designs and methodologies in clinical trials for oncology treatments. Participants will discuss the implications of adaptive trial designs, patient recruitment strategies, and the integration of real-world evidence.

    Track 06
    Cancer Biology: Mechanisms and Targets
    39
    Track Overview

    This session will cover the fundamental mechanisms underlying cancer biology, including genetic mutations and epigenetic modifications. Researchers will present novel therapeutic targets and their potential implications for treatment.

  7. 03:30 PM 04:00 PM

    Interactive Q&A, Day 1 Summary & Group Photo

    Closing interaction and key takeaways from the first day.

    CLOSING
Day 02

Keynote, Technical Sessions & Awards

25 OCT 2026 HYBRID
  1. 09:00 AM 09:15 AM

    Participant Check-in & Day 2 Welcome

    On-site attendance confirmation and virtual lobby access.

    HYBRID
  2. 09:15 AM 10:00 AM

    Keynote Presentation II

    Expert address on the future of the conference research domain.

    PLENARY
  3. 10:00 AM 12:00 PM

    Concurrent Technical Session III

    3 TRACKS
    Track 07
    Health Policy and Cancer Care
    310
    Track Overview

    This track will address the intersection of health policy and oncology, focusing on the implications of policy decisions on cancer care delivery. Discussions will include access to treatments, healthcare disparities, and the impact of legislation on patient outcomes.

    Track 08
    Emerging Technologies in Cancer Treatment
    39
    Track Overview

    This session will explore cutting-edge technologies that are shaping the future of cancer treatment, including artificial intelligence and machine learning applications. Experts will discuss how these innovations can enhance diagnosis, treatment planning, and patient monitoring.

    Track 09
    Pediatric Oncology: Challenges and Innovations
    34
    Track Overview

    This track will focus on the unique challenges and innovative approaches in pediatric oncology. Participants will discuss recent advancements in treatment modalities and the importance of addressing the long-term effects of cancer therapies in children.

  4. 12:00 PM 01:00 PM

    Lunch & Networking Break

    Refreshment interval and professional networking.

    BREAK
  5. 01:00 PM 03:00 PM

    Concurrent Technical Session IV

    2 TRACKS
    Track 10
    Cancer Prevention and Early Detection
    34
    Track Overview

    This session will examine strategies for cancer prevention and the importance of early detection in improving patient outcomes. Researchers will present findings on screening methods, risk assessment, and public health initiatives aimed at reducing cancer incidence.

    Track 11
    Integrative Approaches in Cancer Treatment
    34
    Track Overview

    This track will explore integrative approaches that combine conventional oncology treatments with complementary therapies. Discussions will focus on the evidence supporting these methods and their impact on patient quality of life and treatment efficacy.

  6. 03:00 PM 03:30 PM

    Publications, Best Paper & Best Presentation Awards

    Publication guidance and recognition of outstanding research contributions.

    AWARDS
  7. 03:30 PM 04:00 PM

    Valedictory Session, Closing Remarks & Group Photo

    Conference summary, acknowledgements and formal conclusion.

    CLOSING
Aligned SDGs
3 Good Health and Well-being 4 Quality Education 9 Industry, Innovation and Infrastructure 10 Reduced Inequalities

Be Part of ICOCTI-26

Submit your research or complete your conference registration.